NHGRI Awards $1.2M to Geospiza, Partners to Develop Cancer Variant Detection Application

The funds will be used to develop an application that lets users identify and visualize DNA sequence variations in comparative analyses of normal and cancer tissue samples using Geospiza’s GeneSifter platform

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.